Abstract: A distribution transformer for use in a providing electrical power to sites, includes a ferromagnetic core; a primary winding configured to be connected to a source grid at source grid voltage; and a secondary winding configured to be coupled to service cables to supply electrical energy to at least one of the sites at a first line voltage and at least another of the sites at a second line voltage, wherein the second line voltage is higher than the first line voltage.

Abstract: A failure tolerant data storage access unit with real time capability comprising at least two data volumes and a file requesting handler that handles a file operation request from an application. The file requesting handler is configured to multiply the file operation request at least twice and to forward the multiplied file operation requests to the at least two data volumes ensuring simultaneous and independent processing of the multiplied file operation requests. Further, a failure tolerant data storage access system with real time capability and a method for accessing a data storage are described.

Abstract: A failure tolerant data storage access unit with real time capability comprising at least two data volumes and a file requesting handler that handles a file operation request from an application. The file requesting handler is configured to multiply the file operation request at least twice and to forward the multiplied file operation requests to the at least two data volumes ensuring simultaneous and independent processing of the multiplied file operation requests. Further, a failure tolerant data storage access system with real time capability and a method for accessing a data storage are described.

Abstract: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoictin-associated conditions.

Abstract: A wheeled chair for transporting patients includes a plurality of footrests for supporting a patient's feet thereon. Each footrest is pivotable between an up position and a down position, and includes a biasing mechanism for biasing the footrest toward the up position, or the down position, or whichever of the two positions the footrest is currently closer to. A swing mechanism swings the footrests from a use position in front of the seat to a stowed position alongside the seat. A trigger, such as a button, automatically activates the swinging. The swinging may take place about a vertical axis that is common to the axis about which the front caster wheels swivel. Pivot extensions may be included on the footrests that provide a tool for enabling a caregiver to manually pivot the footrest between the up and down positions with his or her foot.

Abstract: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions.

Abstract: A wheeled chair for transporting patients includes a frame, a seat, a plurality of wheels, and a plurality of armrests. The armrests are pivotable about a common pivot axis that is oriented generally horizontally and that is positioned underneath the seat and forward of a back support. Each armrest may include a locking mechanism for holding the armrests in a use position. When locked in the use position, a user may apply an upward force on the armrests to lift the chair upwardly that does not cause pivoting of the armrests. The chair is designed to allow nesting with other chairs of similar design. The front wheels may be positioned laterally apart a greater distance than the rear wheels to allow a first chair to nestingly receive a rear portion of a second chair. Foley hooks may also be included on the chair for hanging a Foley catheter bag.

Abstract: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions.

Abstract: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions.

Abstract: The disclosure relates to a method and apparatus for compressing woven material or other compressible material, such as, but not limited to, a comforter set or bedding set. The bedding set or other woven material is placed into a reclosable storage bag through the open bottom thereof. The bag is compressed by a compression apparatus and the open bottom of the storage bag is sealed shut. The result is a package with reduced volume, which reduces shipping and display costs, and is more aesthetically attractive to the consumer.

Abstract: The disclosure relates to a method and apparatus for compressing woven material or other compressible material, such as, but not limited to, a comforter set or bedding set. The bedding set or other woven material is placed into a reclosable storage bag which includes a reclosable zipper and a reclosable air valve. With the zipper open, the bag is compressed by a compression apparatus, typically in the absence of vacuum being applied, and, thereafter, the zipper is closed. Straps are wrapped around the compressed bag and the compressed bag is placed into a tote container or similar device. The result is a package with reduced volume, which reduces shipping and display costs, and is more aesthetically attractive to the consumer.

Abstract: The disclosure relates to a method and apparatus for compressing woven material or other compressible material, such as, but not limited to, a comforter set or bedding set. The bedding set or other woven material is placed into a reclosable storage bag which includes a reclosable zipper and a reclosable air valve. With the zipper open, the bag is compressed by a compression apparatus, typically in the absence of vacuum being applied, and, thereafter, the zipper is closed. Straps are wrapped around the compressed bag and the compressed bag is placed into a tote container or similar device. The result is a package with reduced volume, which reduces shipping and display costs, and is more aesthetically attractive to the consumer.

Abstract: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions.

Abstract: The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).

Abstract: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions.

Abstract: The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Abstract: The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

Abstract: The present invention relates to methods of stabilizing the alpha subunit of hypoxia inducible factor (HIF). The invention further relates to methods of preventing, pretreating, or treating conditions associated with HIF, including ischemic and hypoxic conditions. Compounds for use in these methods are also provided.

Abstract: The present invention relates to methods of stabilizing the alpha subunit of hypoxia inducible factor (HIF). The invention further relates to methods of preventing, pretreating, or treating conditions associated with HIF, including ischemic and hypoxic conditions. Compounds for use in these methods are also provided.

Abstract: The present invention relates to methods of stabilizing the alpha subunit of hypoxia inducible factor (HIF). The invention further relates to methods of preventing, pretreating, or treating conditions associated with HIF, including ischemic and hypoxic conditions. Compounds for use in these methods are also provided.